Our promise Blood work, evidence-based treatments, and transparent pricing not guesswork or fads
Achieving a brighter and more even skin tone is a common desire for many of us
What the published research reported A phase-2 randomized trial published in the New England Journal of Medicine in 2023 studied retatrutide in adults with obesity and reported substantial, dose-dependent reductions in body weight over 48 weeks, alongside a gastrointestinal side-effect profile broadly similar to other incretin drugs
Sun C, Wang F, Zhang Y, Yu J, Wang X
Xu J, Wang Y, Jiang C, Cao H, Jiang J, Xu B, Sun T
Cycling protocols vary based on injury severity and goals